Last reviewed · How we verify
cataract surgery
Cataract surgery involves removing the cloudy lens of the eye and replacing it with an artificial lens.
Cataract surgery involves removing the cloudy lens of the eye and replacing it with an artificial lens. Used for Treatment of cataracts.
At a glance
| Generic name | cataract surgery |
|---|---|
| Sponsor | Semler Research Center Pvt. Ltd. |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
The procedure involves making an incision in the cornea, removing the cloudy lens, and then inserting an artificial lens. This helps restore clear vision and reduce symptoms associated with cataracts.
Approved indications
- Treatment of cataracts
Common side effects
- Eye irritation
- Blurred vision
- Eye infection
Key clinical trials
- Reliability and Effectiveness of New Enova Preloaded Intaocular Lens and Cartridge System (NA)
- Feasibility Study of an Accommodating IOL Design (NA)
- Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking (PHASE1, PHASE2)
- Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL) (NA)
- Contralateral Claims Study of Clareon Vivity Pro (NA)
- Reducing Patient Waiting Time for Cataract Surgery (NA)
- Comparison of Phacoemulsification and Corneal Damage Between FLACS and Standard Phaco With Two Handpieces (NA)
- 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cataract surgery CI brief — competitive landscape report
- cataract surgery updates RSS · CI watch RSS
- Semler Research Center Pvt. Ltd. portfolio CI